Predict4All: Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating

• Sponsor: Centre d'Investigation Clinique et Technologique 805 (Other)
• Overall Status: Completed
• CT.gov ID: NCT04210661
• Collaborator: (none)
• Enrollment: 13
• Locations: 2
• Arms: 2
• Actual Duration (Months): 24.8
• Patients Per Site: 6.5
• Patients Per Site Per Month: 0.3

Study Details

Study Description

Brief Summary

The main objective of the PREDICT4ALL project is to provide written communication in a computer, reducing the number of spelling errors for each user.

The effectiveness of written communication is defined in this study by the number of spelling errors for each user. Word prediction (and therefore correction) must be able to be configured by a therapist (speech therapist, occupational therapist).

Adapting the prediction to user errors should also allow it to be more relevant throughout the text input. This software efficiency must increase text input speed, Reduce the cognitive load, establish a classification of spelling errors adapted to the context of text input speed and develop the word prediction module tolerant of these spelling errors.

Condition or Disease	Intervention/Treatment	Phase
Dysorthographia; Neurologic Disorder	Other: prediction software with spell checker	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 13 participants
• Allocation: Randomized
• Intervention Model: Crossover Assignment
• Intervention Model Description: interventionnal, prsopective, randomized, multicentricinterventionnal, prsopective, randomized, multicentric
• Masking: None (Open Label)
• Primary Purpose: Supportive Care
• Official Title: Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating - Predict4All
• Actual Study Start Date: Feb 13, 2020
• Actual Primary Completion Date: Mar 8, 2022
• Actual Study Completion Date: Mar 8, 2022

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: classic prediction software test with classic precition software	Other: prediction software with spell checker; test with prediction software with spell checker
Experimental: prediction software with spell checker test with prediction software with spell checker	Other: prediction software with spell checker; test with prediction software with spell checker

Outcome Measures

Primary Outcome Measures

1. number of spelling errors [20 min]

   total of number of spelling errors during the test

Secondary Outcome Measures

1. Text input speed [20 min]

   Text input speed in the test

2. Prediction usage rate [20 min]

   number of times the prediction is used

3. Keystrokes Saving Rate [5 min]

   measured by the percentage of input saved by word prediction versus a keyboard alone

4. Attentional load [1 min]

   Likert Analog Visual Scale [0-10]

5. Fatigue [1 min]

   Likert Analog Visual Scale [0-10]

6. software Satisfaction [1 min]

   Likert Analog Visual Scale [0-10]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 6 Years to 25 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Aged between 6 and 25 years old For center 1

• patient with dysorthographia

• educational level greater than or equal to CE2

• A developmental level in reading on the Evalouette test (Evaleo battery) greater than or equal to CE1 For center 2

• Neurologic disorder impacting communication

Exclusion Criteria:

• Patient's refusal to participate in the study

• Persons under guardianship

• Pregnant women

• No affiliation to a social security scheme (beneficiary or beneficiary)

• Having visual disturbances preventing the use of the computer tool

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Raymond Poincaré hospital	Garches		France	92380
2	CMRRF Kerpape	Ploemeur		France	56270

Sponsors and Collaborators

• Centre d'Investigation Clinique et Technologique 805

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Centre d'Investigation Clinique et Technologique 805
• ClinicalTrials.gov Identifier: NCT04210661
• Other Study ID Numbers: 2019-A01882-55
• First Posted: Dec 26, 2019
• Last Update Posted: Mar 9, 2022
• Last Verified: Feb 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Centre d'Investigation Clinique et Technologique 805: word prediction; dysorthographia
• Additional relevant MeSH terms: Nervous System Diseases

Study Results

No Results Posted as of Mar 9, 2022